Bert Zbar
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
-
- Renal cell carcinoma treatment
Papers in
-
- Renal and related cancers 3
- Epigenetics and DNA Methylation 2
- Ubiquitin and proteasome pathways 1
-
- Renal cell carcinoma treatment 3
- Co-authors
- Börje Ljungberg (2 shared papers)Colin S. Cooper (2 shared papers)Bruce Beckwith (2 shared papers)Stephan Störkel (2 shared papers)Brett Delahunt (2 shared papers)Göran Roos (2 shared papers)John R. Srigley (2 shared papers)John N. Eble (2 shared papers)
- Journals
- The Journal of Pathology (2 papers)Urology (1 paper)Clinical Cancer Research (1 paper)Cancer Immunology Immunotherapy (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Bert Zbar
8 papers receiving 1.5k citations
Bert Zbar's Hit Papers
Peers
Comparison fields: 5 of 59
- Cancer Research 523
- Pulmonary and Respiratory Medicine 948
- Molecular Biology 796
- Oncology 192
- Surgery 166
Countries citing papers authored by Bert Zbar
This map shows the geographic impact of Bert Zbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Zbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Zbar more than expected).
Fields of papers citing papers by Bert Zbar
This network shows the impact of papers produced by Bert Zbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Zbar. The network helps show where Bert Zbar may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Zbar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Heidelberg classification of renal cell tumours Hit paper breakdown → | 1997 | 1083 |
| 2 | 1994 | 126 | |
| 3 | 2007 | 121 | |
| 4 | 1999 | 90 | |
| 5 | 1997 | 80 | |
| 6 | 1997 | 65 | |
| 7 | 1981 | 20 | |
| 8 | 1993 | 7 |
About Bert Zbar
Bert Zbar is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Surgery, having authored 8 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Renal and related cancers (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related Molecular Pathways (2 papers), Ubiquitin and proteasome pathways (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Cancer Research (523 citations), Pulmonary and Respiratory Medicine (948 citations), Molecular Biology (796 citations), Oncology (192 citations) and Surgery (166 citations). Bert Zbar has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Börje Ljungberg, Colin S. Cooper, Bruce Beckwith, Stephan Störkel, Brett Delahunt, Göran Roos, John R. Srigley, John N. Eble, Stewart Fleming and Victor E. Reuter. Their work appears in journals such as The Journal of Pathology, Urology, Clinical Cancer Research, Cancer Immunology Immunotherapy and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.